Health Expert Mark Borigini, MD shares health management news and commentary at HealthCentral.com. HealthCentral.com is one of the top health destinations on the Web, with more than 35 condition-specific, wellness and general health Web properties. http://www.healthcentral.com/profiles/c/7361/index http://www.healthcentral.com/profiles/c/7361/rss self application/xml en-us 15 120 19 http://www.healthcentral.com/images/hc_logo_sm.gif http://www.healthcentral.com/profiles/c/7361/index http://www.healthcentral.com/osteoporosis/c/7361/10755/afflictions Tue, 26 Jun 2007 10:23:01 -0400 Mark Borigini, MD Recently, an article appeared in the Journal of the National Cancer Institute, suggesting that patients treated with intravenous bisphosphonates are at greater risk of jaw or facial bone deterioration or infection.  But the authors were not sure whether the bisphosphonates caused the bone problem, or whether these patients whose immune systems are suppressed were naturally more prone to such complications.  In fact, there are those... http://www.healthcentral.com/osteoporosis/c/7361/10755/afflictions